(JP¥1,400)
+NT$570 Shipping fee
+NT$65 Agent service fee
Text are automatically translated.
Report translation issueText are automatically translated.
Report translation issueFraud prevention
Customer support
Refund support for customers
Seller info
ありくい
5/51472
View detail
Item condition
Brand New
Ships from
Japan
Category
Bundle & Save : Our users save an average of 35% on shipping fees by bundling multiple items!
Something went wrong, please try again later.
Something went wrong, please try again later.
Internal Medicine Comprehensive Journal Journal "Diagnosis and Treatment" 2024 Vol. 112 No. 11 Dangerous Diseases Not to Be Missed in Outpatient Clinics, Cases to Consult Price: ¥2970 From the official HP: Objective: Yasushi Miyake Perspective of the Sender: Recognizing Dangerous Complaints and Signs From the perspective of a private practitioner: Hiroaki Higashika From the perspective of a general internal medicine department at a university hospital: Naoko Tatezawa, Toshiyo Sagawa From the perspective of an emergency physician at a psychiatric hospital: Yoshitsugu Umehara Perspective of the Receiver: Hints Leading to Diagnosis Cerebrovascular disorders (stroke): Hiroshi Moriwaki Neurological diseases other than stroke: Eisei Hoshiyama Cardiovascular diseases (heart and great vessels): Yuko Yamamoto Thoracic diseases: Kei Hayakawa Acute abdominal conditions: Maki Kitamura, Taiichiro Sumiyama Infectious diseases: Shigemasa Taguchi Endocrine and metabolic diseases: Yuichi Kojima Pediatric emergency: Takashi Miyagi Skin diseases: Kotaro Matsui Limb trauma: Kentaro Matsui Psychiatric emergency: Kosuke Hino Effects of medication: Masayuki Yoshikawa, Satoru Aoki, Tatsuro Tamazukuri Methodology: Determining Urgency and Severity Advanced Medical Life Support (AMLS): Satoshi Takeda JTAS: Symptom list and supplementary factors: Takashi Okudera, Mizuho Ii, Kumiko Sakata Internal Medicine Emergency Guidelines 2022 and JMECC Program: Koichiro Abe Roundtable Discussion The relationship between uric acid and cardiovascular and kidney diseases - from the perspective of residual CVD risk - Provided by: Fuji Yakuhin Co., Ltd. Special Feature Treatment of Basedow's disease with 5 mg thiamazole every other day and 2.5 mg tablets daily - Evaluation of blood concentration using mass spectrometry - Kazuhiko Horiguchi, Kentaro Takahashi Examination of Basedow's disease exacerbation factors - Stress and exacerbation - Evaluation by mass spectrometry - Mai Asano Series How to view the pharynx for generalists I can't speak well! Takashi Fujiwara Featured New Drugs Viroi® (Zolbetuximab): Shimpei Ushiyama, Genma Nakayama, Kohei Setara A lawyer answers! Legal consultation clinic Tell me! Patient harassment (measures against violence and harassment in medical settings) - How to respond to disruptive behavior - Takeshi Matsumura #book
2 months ago